AstraZeneca/Oxford vaccine effective against UK Covid-19 strain, data shows

New data has shown that the Covid-19 vaccine developed by AstraZeneca and Oxford University is effective against the variant of the virus first discovered in the UK. The variant, known as B.1.1.7, has an unusually high number of mutations and transfers more rapidly than the ones first discovered. The vaccine was found to have similar efficacy to this variant as it was found in previous variants.